NCT00282919View on ClinicalTrials.gov

A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Falciparum Malaria
Interventions
DRUG

Azithromycin plus chloroquine

dose of 2000 mg Azithromycin plus 600 mg chloroquine base

Trial Locations (2)

403002

Pfizer Investigational Site, Bambolim

Unknown

Pfizer Investigational Site, Tumaco

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00282919 - A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria | Biotech Hunter | Biotech Hunter